Be sure to check our sister interview main ratings news website

DNL

Hardman & Co

Diurnal Group Plc Get the rhythm

27th October 2016

Diurnal Group Plc (LON:DNL) is a clinical stage specialty pharmaceutical company focused on diseases of the endocrine system. It has two lead candidates – Infacort® and Chronocort® – in Phase

Interviews

MetalNRG Plc CEO Christopher Chadwick Discusses Key Developments and Future Plans (VIDEO)
MetalNRG Plc CEO Christopher Chadwick Discusses Key Developments and...
MetalNRG Plc (LON:MNRG) CEO Christopher Chadwick...
Cizzle Biotechnology Expanding into USA and Transforming Cancer Screening (VIDEO)
Cizzle Biotechnology Expanding into USA and Transforming Cancer Screening...
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman...
Pulsar Helium CEO Discusses LSE IPO, High-Purity Helium and Expansion Strategies (VIDEO)
Pulsar Helium CEO Discusses LSE IPO, High-Purity Helium and...
Pulsar Helium Inc. (LON:PLSR, TSXV:PLSR, OTCQB:PSRHF)...
Challenger Energy CEO Discusses Chevron Deal and Upcoming Projects in Uruguay (VIDEO)
Challenger Energy CEO Discusses Chevron Deal and Upcoming Projects...
Challenger Energy Group (LON:CEG) CEO Eytan...
Cerillion CEO Louis Hall on Link Mobility’s Upgrade and Future Growth Strategies (VIDEO)
Cerillion CEO Louis Hall on Link Mobility’s Upgrade and...
Cerillion plc (LON:CER) CEO Louis Hall...

Funds

US corporate results lift market as investors watch for further economic data
US corporate results lift market as investors watch for further economic data
Understanding Real Estate Credit
Understanding Real Estate Credit
European stocks show signs of optimism as companies report positive earnings
European stocks show signs of optimism as companies report positive earnings
Emerging Markets: Is a recovery on the horizon?
Emerging Markets: Is a recovery on the horizon?
The transformation of the corporate credit market
The transformation of the corporate credit market
European stock market and the economic outlook
European stock market and the economic outlook

Presentations

Pennant International Maximising operational efficiency
Pennant International Maximising operational efficiency
Pennant International Group (LON:PEN) CEO Phil...
Norcros Results Year ended 31 March 2024, Strategic Success and Sustainable Growth
Norcros Results Year ended 31 March 2024, Strategic Success...
This Norcros plc (LON:NXR) presentation with CEO...
SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO
SAE Renewables Future Strategy to 2035 and Investment Case...
SAE Renewables Limited (LON:SAE) Chief Executive...
One Health Group (AQSE:OHGR) final results presentation
One Health Group (AQSE:OHGR) final results presentation
One Health Group (AQSE:OHGR) final results...
Cerillion CEO & CFO present stellar H1 2024 interim results
Cerillion CEO & CFO present stellar H1 2024 interim...
Cerillion plc (LON:CER) Interim results presentation...

Broker Talk

Volta Finance: Robust returns and discounted value highlight investment opportunity
Volta Finance: Robust returns and discounted value highlight investment opportunity
Shield Therapeutics: Strong H1 ’24 Sales and Cashflow Outlook for H2 ’25
Shield Therapeutics: Strong H1 ’24 Sales and Cashflow Outlook for H2 ’25
City of London Investment Company sees positive growth in Q4 and FY24 FUM
City of London Investment Company sees positive growth in Q4 and FY24 FUM
Expertise and strategic asset management in an under-supplied market
Expertise and strategic asset management in an under-supplied market
Global perspective and market positioning of pawnbroking for H&T Group
Global perspective and market positioning of pawnbroking for H&T Group
Duke Capital: Record cashflows, High dividend yield and Growth potential
Duke Capital: Record cashflows, High dividend yield and Growth potential

© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.